G

GlycoMimetics
D

GLYC

0.18020
USD
-0.00
(-1.48%)
مغلق
حجم التداول
8,529
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
11,625,398
أصول ذات صلة
A
ADMA
-1.700
(-8.74%)
17.760 USD
AMGN
AMGN
-13.59
(-4.38%)
294.28 USD
C
CRBP
-0.09000
(-1.83%)
4.84000 USD
REGN
REGN
-32.25
(-5.28%)
578.63 USD
R
RGNX
-0.39700
(-5.93%)
6.29300 USD
المزيد
الأخبار المقالات

العنوان: GlycoMimetics

القطاع: Healthcare
الصناعة: Biotechnology
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.